$1.58 +0.17 (11.81%)

Cibus, Inc. Class A Common Stock (CBUS)

Cibus, Inc. Class A (CBUS) is a biotechnology company focused on developing innovative gene-editing technologies for agriculture. They aim to create healthier, more sustainable crops through precise and efficient genetic modifications, helping to address global food security and environmental challenges.

🚫 Cibus, Inc. Class A Common Stock does not pay dividends

Company News

What's Driving Cibus Inc.'s Pre-Market Surge Amid Trump's China Trade Warning?
Benzinga • Mohd Haider • October 15, 2025

Cibus Inc. experienced a pre-market surge of 23.81% following President Trump's trade comments about China, specifically regarding soybeans and cooking oil trade tensions.

Cibus, Inc. Announces Closing of $27.5 Million Public Offering
GlobeNewswire Inc. • N/A • June 10, 2025

Cibus, Inc., a leading agricultural biotechnology company, announced the closing of a $27.5 million public offering to fund further development of its weed management productivity traits in Rice and for working capital and general corporate purposes.

Wall Street Breakfast: The Week Ahead
Seeking Alpha • Wall Street Breakfast • June 16, 2024

Stay updated on Wall Street news with our daily podcast available on Seeking Alpha, iTunes, and Spotify.

Cibus (CBUS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research • Zacks Equity Research • May 9, 2024

Cibus (CBUS) delivered earnings and revenue surprises of -10.89% and 36.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?